70709-0192 CAVHANZA - CanMED: NDC

Product NDC:

70709-0192

Brand Name:

CAVHANZA

Generic Name:

Nilotinib

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: NILOTINIB

Strength: 80.0

Unit: mg/1

Packages:

Code: 70709-0192-12

Description: 112 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (70709-192-12)

Effective Date: June 30, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox